Next, we quantified the lifetime risk of ILD for four groups: (1) MUC5B non-carriers in the population, (2) MUC5B carriers in the population, (3) MUC5B non-carriers with RA and (4) MUC5B carriers with RA (figure 1, table 1). Here, MUC5B is linked to interstitial lung disease.